| 标题 |
Results From the Phase III Randomized Trial of Onartuzumab Plus Erlotinib Versus Erlotinib in Previously Treated Stage IIIB or IV Non–Small-Cell Lung Cancer: METLung |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of Clinical Oncology 作者:David R. Spigel; Martin J. Edelman; Kenneth J. O’Byrne; Luis Paz‐Ares; Simonetta Mocci; et al 出版日期:2017-02-01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)